Scientists are continuously searching for possible solutions against HNSCC, including immunotherapy that is strongly related to different immune cells consisting of tumor microenvironments, such as PD1/PDL1 [17], and regular medical treatment with chemotherapy. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.